Jiangsu Hillgene Biopharmaceutical Co., Ltd.
PrivateCompany Overview
Jiangsu Hillgene Biopharmaceutical Co., Ltd. operates in Healthcare & Life Sciences and is based in Suzhou. It was founded in 2017.
Jiangsu Hillgene Biopharmaceutical Co., Ltd. is a biotechnology company that provides comprehensive Cell and Gene Therapy Contract Development and Manufacturing Organization (CQDMO) services for cell therapy products.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Quality Management
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Jiangsu Hillgene Biopharmaceutical Co., Ltd. Comparables
Compare Jiangsu Hillgene Biopharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| uBriGene Biosciences | 86% | |
| CoJourney | 83% | |
| OBiO Technology | 81% |
For institutional investors. Book with your work email.
Jiangsu Hillgene Biopharmaceutical Co., Ltd. Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 6, 2025
Grew 21% QoQ from 14 to 17 employees.
- Jan 14, 2025
Grew 100% QoQ, from 9 to 18 employees.
For institutional investors. Book with your work email.
Jiangsu Hillgene Biopharmaceutical Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Jiangsu Hillgene Biopharmaceutical Co., Ltd.'s valuation, stock price, and market status.
Is Jiangsu Hillgene Biopharmaceutical Co., Ltd. a public or private company?
Jiangsu Hillgene Biopharmaceutical Co., Ltd. is a private company.
What is the current stock price of Jiangsu Hillgene Biopharmaceutical Co., Ltd.?
Jiangsu Hillgene Biopharmaceutical Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Jiangsu Hillgene Biopharmaceutical Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Jiangsu Hillgene Biopharmaceutical Co., Ltd. worth (valuation)?
Valuation information for Jiangsu Hillgene Biopharmaceutical Co., Ltd. is not publicly available.
Can I buy Jiangsu Hillgene Biopharmaceutical Co., Ltd. stock?
Jiangsu Hillgene Biopharmaceutical Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Jiangsu Hillgene Biopharmaceutical Co., Ltd.'s last funding round?
Funding round information for Jiangsu Hillgene Biopharmaceutical Co., Ltd. is not publicly available.
Who are the main investors in Jiangsu Hillgene Biopharmaceutical Co., Ltd.?
Investor information for Jiangsu Hillgene Biopharmaceutical Co., Ltd. is not publicly disclosed.
Will Jiangsu Hillgene Biopharmaceutical Co., Ltd. IPO soon?
No public IPO plans have been announced for Jiangsu Hillgene Biopharmaceutical Co., Ltd..
How can I track Jiangsu Hillgene Biopharmaceutical Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Jiangsu Hillgene Biopharmaceutical Co., Ltd.'s shares on secondary markets.